BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 36628908)

  • 21. Transoral robotic surgery versus nonrobotic resection of oropharyngeal squamous cell carcinoma.
    Chillakuru Y; Benito DA; Strum D; Mehta V; Saini P; Shim T; Darwish C; Joshi AS; Thakkar P; Goodman JF
    Head Neck; 2021 Jul; 43(7):2259-2273. PubMed ID: 33899949
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Magnetic resonance imaging based radiomics prediction of Human Papillomavirus infection status and overall survival in oropharyngeal squamous cell carcinoma.
    Boot PA; Mes SW; de Bloeme CM; Martens RM; Leemans CR; Boellaard R; van de Wiel MA; de Graaf P
    Oral Oncol; 2023 Feb; 137():106307. PubMed ID: 36657208
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predictors of Mortality in HPV-Associated Oropharynx Carcinoma Treated With Surgery Alone.
    Han M; Stanford-Moore GB; Larson AR; Schoppy DW; Cognetti DM; Joshi AS; Houlton JJ; Ryan WR
    Laryngoscope; 2020 Jul; 130(7):E423-E435. PubMed ID: 31675132
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Retrospective study of the clinicopathological characteristics and prognosis of elderly patients with oropharyngeal squamous cell carcinoma.
    Li Y; Jiang B; Huang M; Wang G; Bai Y; Huang W
    J Int Med Res; 2021 Jun; 49(6):3000605211016662. PubMed ID: 34082601
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Surgical salvage improves overall survival for patients with HPV-positive and HPV-negative recurrent locoregional and distant metastatic oropharyngeal cancer.
    Guo T; Qualliotine JR; Ha PK; Califano JA; Kim Y; Saunders JR; Blanco RG; D'Souza G; Zhang Z; Chung CH; Kiess A; Gourin CG; Koch W; Richmon JD; Agrawal N; Eisele DW; Fakhry C
    Cancer; 2015 Jun; 121(12):1977-84. PubMed ID: 25782027
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The clinical value of oral robotic surgery in the treatment of oropharyngeal squamous cell carcinoma].
    Zhang X; Yang ZY; Yang AK; Zhang Q; Li QL; Chen SW; Chen JT; Song M
    Zhonghua Zhong Liu Za Zhi; 2022 Jun; 44(6):570-576. PubMed ID: 35754232
    [No Abstract]   [Full Text] [Related]  

  • 27. Association of adjuvant radiation and survival in human papilloma virus-positive oropharynx squamous cell carcinoma with lymphovascular invasion as the sole adverse pathologic feature.
    Hong SA; Armstrong AT; Snow K; Walker RJ; Massa ST
    Head Neck; 2024 May; 46(5):1043-1050. PubMed ID: 38511301
    [TBL] [Abstract][Full Text] [Related]  

  • 28. De-intensified adjuvant (chemo)radiotherapy versus standard adjuvant chemoradiotherapy post transoral minimally invasive surgery for resectable HPV-positive oropharyngeal carcinoma.
    Howard J; Dwivedi RC; Masterson L; Kothari P; Quon H; Holsinger FC
    Cochrane Database Syst Rev; 2018 Dec; 12(12):CD012939. PubMed ID: 30550641
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of Race and Insurance Status on Primary Treatment for HPV-Associated Oropharyngeal Squamous Cell Carcinoma.
    Habib AM; Carey RM; Prasad A; Mady LJ; Shinn JR; Bur AM; Brody RM; Cannady SB; Rajasekaran K; Ibrahim SA; Newman JG; Brant JA
    Otolaryngol Head Neck Surg; 2022 Jun; 166(6):1062-1069. PubMed ID: 34253112
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Females Have Worse Overall and Disease-Specific Survival in Human Papillomavirus-Negative Oropharyngeal Squamous Cell Carcinoma.
    Hunter WP; Harris JA; Lee CC; Cheng AC; Peacock ZS
    J Oral Maxillofac Surg; 2022 Jul; 80(7):1260-1271. PubMed ID: 35469827
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human papillomavirus co-infection and survival in oral and oropharyngeal squamous cell carcinoma: A study in 235 Brazilian patients.
    Silveira HA; Almeida LY; Carlos R; Silva EV; Ferrisse TM; Duarte A; Cardoso SCS; Polanco XBJ; Bufalino A; Ribeiro-Silva A; León JE
    Auris Nasus Larynx; 2022 Apr; 49(2):258-270. PubMed ID: 34274177
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MMP-7 expression may influence the rate of distant recurrences and disease-specific survival in HPV-positive oropharyngeal squamous cell carcinoma.
    Vento SI; Jouhi L; Mohamed H; Haglund C; Mäkitie AA; Atula T; Hagström J; Mäkinen LK
    Virchows Arch; 2018 Jun; 472(6):975-981. PubMed ID: 29721609
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of clinical complete response on treatment outcomes in patients with locally advanced HPV-negative oropharyngeal squamous cell carcinoma.
    De Felice F; Musio D; Abate G; Moscarelli E; Bulzonetti N; Tombolini V
    J Cancer Res Clin Oncol; 2020 Feb; 146(2):477-483. PubMed ID: 31686249
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Radiation therapy dose de-escalation compared to standard dose radiation therapy in definitive treatment of HPV-positive oropharyngeal squamous cell carcinoma.
    Gabani P; Lin AJ; Barnes J; Oppelt P; Adkins DR; Rich JT; Zevallos JP; Daly MD; Gay HA; Thorstad WL
    Radiother Oncol; 2019 May; 134():81-88. PubMed ID: 31005228
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Distribution of Cervical Lymph Node Metastases From Squamous Cell Carcinoma of the Oropharynx in the Era of Risk Stratification Using Human Papillomavirus and Smoking Status.
    Amsbaugh MJ; Yusuf M; Cash E; Silverman C; Wilson E; Bumpous J; Potts K; Perez C; Bert R; Redman R; Dunlap N
    Int J Radiat Oncol Biol Phys; 2016 Oct; 96(2):349-353. PubMed ID: 27598805
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stage I HPV-positive oropharyngeal cancer: Should all patients receive similar treatments?
    Yoshida EJ; Luu M; Mallen-St Clair J; Mita AC; Scher KS; Lu DJ; Nguyen AT; Shiao SL; Ho AS; Zumsteg ZS
    Cancer; 2020 Jan; 126(1):58-66. PubMed ID: 31536144
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The prognostic significance of the biomarker p16 in oropharyngeal squamous cell carcinoma.
    Oguejiofor KK; Hall JS; Mani N; Douglas C; Slevin NJ; Homer J; Hall G; West CM
    Clin Oncol (R Coll Radiol); 2013 Nov; 25(11):630-8. PubMed ID: 23916365
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HPV-Positive Oropharyngeal Carcinoma: A Systematic Review of Treatment and Prognosis.
    Wang MB; Liu IY; Gornbein JA; Nguyen CT
    Otolaryngol Head Neck Surg; 2015 Nov; 153(5):758-69. PubMed ID: 26124261
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anatomical subsite modifies survival in oropharyngeal squamous cell carcinoma: National Cancer Database study.
    Tham T; Ahn S; Frank D; Kraus D; Costantino P
    Head Neck; 2020 Mar; 42(3):434-445. PubMed ID: 31773842
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical outcomes in relapsed oropharyngeal cancer after definitive (chemo) radiotherapy.
    De Felice F; Bird T; Michaelidou A; Jeannon JP; Simo R; Oakley R; Lyons A; Fry A; Cascarini L; Asit A; Thavaraj S; Reis Ferreira M; Petkar I; Kong A; Lei M; Guerrero Urbano T
    Oral Dis; 2023 Mar; 29(2):595-603. PubMed ID: 34338394
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.